CURR Archives - Blue Horseshoe Stocks

More Major Options Gainers

More New Highs Options

When we updated readers on our bitcoin related options plays yesterday morning, we had already witnessed gains in the neighborhood of 200% We made sure to caution our readers that we expected to see further gains in all targets based on the surging price of bitcoin, which has now surpassed $38K/BTC.

Our expectations were met to the letter, as the following new highs were tacked on. Here are the total possible gains that were on the table following our signaling of these targets:

RIOT Weekly $17-19 Calls
$17: .65-2.75 (+323%)
$18: .52-2.96 (+469%)
$19: .35-2.20 (+529%)
______

MARA 01/15 $11-12 Calls
$11: 1.32-6.69 (+407%)
$12: 1.06-5.81 (+448%)
______

MARA 01/15 $13-15 Calls
$13: .80-5.00 (+525%)
$14: .62-4.27 (+589%)
$15: .50-3.65 (+630%)

Once again today, we feel as if more new highs are on the way for these contract sets, but we also want to stay at the money with our potential strikes, so we are going to add the MARA 01/15 $20 Calls and the RIOT Weekly $20-21 Calls.

Cannabis Plays Coming Back

With the democrats winning control of the US senate in the GA runoffs, the odds of finally seeing marijuana reclassified at the federal level sooner rather than later, have now gone up considerably. Thus we would like to signal a couple of ideas related to the cannabis space, and will likely be more focused on related stock and options ideas going forward.

CGC Weekly $31-31.50 Calls
TLRY Weekly $11.50-12 Calls

More Fresh Options Ideas

STZ Weekly $225-230 Calls
BBBY Weekly $20-19 Puts
WBA Weekly $43.50-44 Calls

CURR NEWS:

OXNARD, Calif.–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp (“CURE” or the “Company”) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company’s Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here through registration and will be available online until January 14. (>>View Full PR)

Extended Watchlist:
ALYI, BLSP, KSHB, LRDC, INTV

CURR News Update & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

We’re looking back in on CURR this morning on the heels of a key PR released by the company that we would like to share with our readers. We have been following this stock for roughly a month, and this FDA IND approval news is by far the most exciting development yet.

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for its product CUREfilm Blue™, an oral soluble film of sildenafil citrate (the active ingredient present in Viagra®¹) for the treatment of erectile dysfunction (ED). CURE is seeking approval of this product via the 505(b)(2) regulatory pathway to expedite the U.S. approval process. (>>View Full PR via OTCMARKETS)

In addition to familiarizing yourself with the company’s news update, we would recommend you take a couple of minutes to check out the video presentation of the CURR chart that we have provided below:

______

Please direct any investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Fresh Options Ideas:
SPY 01/06 $368-367 Puts

Extended Watchlist:
TSPG, WDLF, ISWH, USRM, OZSC, LBRMF

Bitcoin Related Options & More

Bitcoin Boom Related Ideas

With Bitcoin values pushing past $28K we want to start of this morning by identifying some related options ideas. In addition RIOT and MARA, which are directly connected to btc, we will also be entertaining an idea for OSTK, which seems to have a tendency to run concurrently with the digital currently.

Our specific targets in each of these potential plays are going to be as follows:

RIOT Weekly $15-16 Calls
MARA 01/15 $13-15 Calls
OSTK Weekly $47.50-58 Calls
_____

Bonus Idea:

Unrelated to Bitcoin, we also want to signal some calls in AZN as the company hopes its COVID-19 shot developed in conjunction with Oxford University will receive UK approval presently. We’re going to radar the AZN 01/08 $50-52 Calls.

Optech International Inc. OPTI

We have been tracking a relatively large amount of OTC stocks compared to what has become typical for us over the years. The most recent success story there happened last week in the form of OPTI, as we mentioned the stock in our reports from Wednesday and Thursday morning.

On Wednesday, we observed a low of .0576 which gave way to a new high of .0914 on Thursday. That works out to an overall move of 59%, a figure we would expect to see increase with the resumption of trading today based on the premarket activity we’re observing this morning.

Extended Watchlist:
CURR, PBIO, AITX, DSGT, ENZC, FUTL,

CURR Form-4 Alert, Options & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR) – Form-4 Alert

We’re circling back around to CURR for a few different reasons today. Firstly, the company was featured in an article yesterday on Seeking Alpha that identified it as one of the 20 most undervalued stocks with ties to the cannabis sector. (>>View Article)

Additionally, whenever we are tracking a particular company and notice the submission of a Form-4 (insider buying) we always take note, and one came in yesterday. CEO Robert Davidson increased his position, which you can verify by perusing the form. (>>View Form-4)

Lastly, as were recently mentioning about CURR in a previous report, the company held a Zoom webcast last Thursday pertaining to its current strategic positioning and direction. You can now view the entirety of the presentation without registering, on YouTube, and we would suggest that our readers do just that at their first opportunity. (>>View CURR Webcast – Total Runtime, 35:38)
______

Please direct any investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Massive Options Success:

All of our options ideas from yesterday morning’s premarket report immediately bore fruit. We timed the bottom bounce on SWI perfectly as the stock ran 13% from 14.975-16.94, made a timely earnings play on NKE, and bet that the SPY, which was falling in the premarket, would rebound. The markets predictably dipped and ripped, and helped to provide all of the following intraday gain opportunities:

SWI 02/19 $12.50-17.50 Calls
$12.50: 3.97-5.30 (+34%)
$15: 2.25-3.80 (+69%)
$17.50: 1.80-2.60 (+44%)
_____

SPY 12/23 $365-367 Calls
$365: 1.95-4.80 (+146%)
$366: 1.54-4.10 (+166%)
$367: 1.12-3.39 (+202%)
_____

NKE Weekly (12/24) $142-145 Calls
$142: 2.71-6.40 (+136%)
$143: 2.09-5.59 (+167%)
$144: 1.78-4.90 (+175%)
$145: 1.38-4.20 (+204%)

In the case of the SPY and SWI, which are both gapping up big here in the premarket, we would expect to see our observed ranges and potential gains increase today.

_____

Fresh Options Idea:
KMX Weekly $99-97.50 Puts

Extended Watchlist:
BSRC, PTTN, AMLH, JNSH, GAXY, FDBL

Finishing Up a Solid Trading Week

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we mentioned in Wednesday morning’s premarket report, CURE officials conducted a Zoom webcast on the current state of the company yesterday afternoon. Today we just wanted to remind our readers that if you were unable to catch the presentation live, you can still get it on demand at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

CURE has a lot happening right now, so we would highly suggest getting the story straight from the horse’s mouth and hearing what company directors had to say.
_______

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Options Recaps

Our LEN and ACN idfeas from yesterday’s report panned out pretty well, and we have a couple of fresh ideas to add to the mix as well.

LEN Weekly $75.50-77 Calls
$75.50: 2.55-6.14 (+140%)
$76: 2.26-5.60 (+148%)
$76.50: 1.51-5.10 (+238%)
$77: 1.35-4.90 (+263%)
_______

ACN Weekly $255-262.50 Calls
$255: 9.99-15.00 (+50%)
$257.50: 8.19-12.30 (+50%)
$260: 5.79-10.01 (+73%)
$262.50: 4.15-9.00 (+117%)
______

Fresh Options Ideas:
WGO Weekly $60 Calls
DRI Weekly $115 Calls

Extended Watchlist:
BSRC, CEOS, SAML, TEUM, BCII, CBGH